Literature DB >> 16937463

Extraintestinal manifestations and complications in inflammatory bowel diseases.

Katja S Rothfuss1, Eduard F Stange, Klaus R Herrlinger.   

Abstract

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBD) that often involve organs other than those of the gastrointestinal tract. These nonintestinal affections are termed extraintestinal symptoms. Differentiating the true extraintestinal manifestations of inflammatory bowel diseases from secondary extraintestinal complications, caused by malnutrition, chronic inflammation or side effects of therapy, may be difficult. This review concentrates on frequency, clinical presentation and therapeutic implications of extraintestinal symptoms in inflammatory bowel diseases. If possible, extraintestinal manifestations are differentiated from extraintestinal complications. Special attention is given to the more recently described sites of involvement; i.e. thromboembolic events, osteoporosis, pulmonary involvement and affection of the central nervous system.

Entities:  

Mesh:

Year:  2006        PMID: 16937463      PMCID: PMC4087615          DOI: 10.3748/wjg.v12.i30.4819

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  134 in total

1.  Kidney granuloma in Crohn's disease.

Authors:  A J Archimandritis; M S Weetch
Journal:  BMJ       Date:  1993-08-28

2.  A four-year longitudinal study of bone loss in patients with inflammatory bowel disease.

Authors:  R J Motley; D Clements; W D Evans; E O Crawley; C Evans; J Rhodes; J E Compston
Journal:  Bone Miner       Date:  1993-11

3.  Venous thromboembolism in inflammatory bowel disease.

Authors:  Craig A Solem; Edward V Loftus; William J Tremaine; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

4.  Acute pancreatitis in Crohn's disease.

Authors:  P Weber; F Seibold; H Jenss
Journal:  J Clin Gastroenterol       Date:  1993-12       Impact factor: 3.062

5.  Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease.

Authors:  Necla Songür; Yildiran Songür; Meriç Tüzün; Ibrahim Doğan; Dilek Tüzün; Arzu Ensari; Baki Hekimoglu
Journal:  J Clin Gastroenterol       Date:  2003-10       Impact factor: 3.062

6.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

Authors:  Karen Vanessa Winther; Tine Jess; Ebbe Langholz; Pia Munkholm; Vibeke Binder
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

7.  Inflammatory bowel disease and the risk of fracture.

Authors:  Tjeerd-Pieter van Staa; Cyrus Cooper; Listy Samuels Brusse; Hubert Leufkens; Muhammad K Javaid; Nigel K Arden
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody.

Authors:  S Bhagat; K M Das
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

9.  Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.

Authors:  D Clements; J E Compston; W D Evans; J Rhodes
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

Review 10.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

View more
  90 in total

1.  Pulmonary manifestations in inflammatory bowel disease: a prospective study.

Authors:  Devendra Desai; Samir Patil; Zarir Udwadia; Shailendra Maheshwari; Philip Abraham; Anand Joshi
Journal:  Indian J Gastroenterol       Date:  2011-09-21

2.  Acute dacryoadenitis in Crohn's disease.

Authors:  Vijay Wagh; S V Raman; R Parrish
Journal:  BMJ Case Rep       Date:  2010-08-03

Review 3.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  Recent advances in understanding ulcerative colitis.

Authors:  Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-11-09       Impact factor: 3.397

Review 5.  Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Authors:  Paul E Evans; Darrell S Pardi
Journal:  MedGenMed       Date:  2007-03-19

6.  Adalimumab-induced IgA nephropathy.

Authors:  Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 7.  Pancreatic disorders in inflammatory bowel disease.

Authors:  Filippo Antonini; Raffaele Pezzilli; Lucia Angelelli; Giampiero Macarri
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 8.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

9.  Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Authors:  Deepak K Kadayakkara; Pamela L Beatty; Michael S Turner; Jelena M Janjic; Eric T Ahrens; Olivera J Finn
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

10.  Relationship and significance between anti-beta2-glycoprotein I antibodies and platelet activation state in patients with ulcerative colitis.

Authors:  Yan-Hang Gao; Pu-Jun Gao; Chun-Guang Wang; Xiao-Cong Wang; Yun-Feng Piao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.